With revolutionary technology, they all could usher in a new era of exciting, transformative medicine.
Trade This Stock for a 27%-60% Potential Return in the Next 3-6 Months
by
•It just broke out of a falling wedge pattern and looks poised for an upmove in the short-term.
Analyst Thinks This $1 Stock Has Triple-Digit Upside Potential
by
•Among many bullish indicators, it just broke out with historic high volume.
Upgrades and Downgrades for Thursday, 1/19
by
•Here are today’s upgrades and downgrades: IBM, Philip Morris, VF Corp., Ubisoft, Roblox, Teva, Charles Schwab and more.
It’s Time to Buy This Growth Stock Again
by
•Part of a booming industry, investors who buy and hold long term will do well.
This Stock is Likely to Continue to Underperform
by
•Until the tech giant begins to implement a large-scale cost reduction plan and address growing competitive risks, there’s little reason to dive back into the stock today.
Tesla (TSLA) Stock Looks Poised for a Surge
by
•Our target potential upside is 11% to 18% in the next 3 to 6 months.
7 of the Best Growth Stocks to Buy Now
by
•With some signs of optimism in the stock market, these seven names should post superior returns in 2023.
Upgrades and Downgrades for Wednesday, 1/18
by
•Here are today’s upgrades and downgrades: Exxon Mobil, IBM, PayPal, Nestle, Shell, BP, Yeti and more.
2 Stocks That Could Double in 2023
by
•When market sentiment shifts, these beaten-down names are ripe for a comeback.